Article Details
Retrieved on: 2022-11-15 05:19:42
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche's experimental treatment gantenerumab used a similar approach to that of Eisai Co. and Biogen Inc., which two months ago scored a rare ...
Article found on: www.swissinfo.ch
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here